Adjuvant use of fibrin glue (FG) in the fistula tract has been shown to promote closure of
low-output ECFs. The primary objectives of this study are to compare the clinical efficacy,
safety of autologous platelet-rich fibrin glue (PRFG) and a commercially available fibrin
sealant Bioseal® in the management of patients with low-output volume ECFs.